PhRMA CEO Stephen Ubl sits down with CNBC's Annika Kim Constantino to discuss PhRMA's launch of America Cures and the ...
A survey last fall by Natixis Investment Managers found that 74% of institutional money managers expect a market correction ...
The American Academy of Pediatrics (AAP) and other leading medical organizations have sued in a bid to stop the new ...
Merck & Co., Inc. (NYSE:MRK) is included among the 16 Best Dividend Stocks with Rising Payouts. On February 13, Deutsche Bank ...
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” ...
Zacks Investment Research on MSN
Merck vs. Bristol Myers: Which pharma stock is a better pick in 2026?
Merck & Co. MRK and Bristol Myers Squibb BMY are major global drugmakers with expansive, diversified portfolios. Merck stands ...
Merck is sending hazardous waste from its Riverside Cherokee plant off-site for treatment and disposal, according to the Pennsylvania Department of Environmental Protection.
Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can ...
Merck (MRK) reports positive Phase 3 SMART trial results for ENFLONSIA in high-risk infants/children vs RSV, with consistent safety and dosing—read ...
After winning an initial U.S. nod in July 2023, Beyfortus has gone on to do gangbusters for Sanofi and AZ, growing total sales 9.5% last year for a total haul of 1.78 billion euros (roughly $2.1 ...
Merck & Co. Inc. MRK on Wednesday announced a strategic collaboration with Mayo Clinic to leverage artificial intelligence ...
Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results